Chinese herbal formula Regan Saibisitan alleviates inflammation and improves chronic bronchitis via inhibiting the JAK2/STAT3 pathway

Author:

Ding Xiaorui1,Zheng Ruifang2,Kader Kaderyea2,Han Yulin,Xu Lei2,Zeng Xin1,Xing Jianguo1,Wang Shoubao3

Affiliation:

1. Shihezi University School of Pharmacy

2. Xinjiang Key Laboratory of Uygur Medicine, Xinjiang Institute of Materia Medica

3. Chinese Academy of Medical Sciences and Peking Union Medical College

Abstract

Abstract

Background: Chronic bronchitis (CB) is characterized by persistent, non-specific inflammation in the trachea, bronchial mucosa, and surrounding tissues mainly resulting from infectious or non-infectious factors. Regan Saibisitan is a classic prescription used to treat cough, pneumonia, and other respiratory infections in Uygur medicine. However, its mechanism in treating chronic bronchitis has not been reported. This study aimed to explore the efficacy and mechanism of Regan Saibisitan in CB mice. Methods: Regan Saibisitan extract (RGS) was prepared, and the components in RGS were analyzed by ultra-performance liquid chromatography-ion trap-electrostatic field orbital trap mass spectrometry (UPLC-LTQ-Orbitrap-MS/MS). The CB mouse model was established by cigarette smoking (CS) and intranasal administration of lipopolysaccharide (LPS, 20μg), histological changes of bronchial epithelium, collagen deposition, mucus secretion in lung tissue and inflammatory factors were assayed. Transcriptomics analysis was performed to detect the differentially regulated genes in lung tissue of CB mice treated with RGS. The effect of RGS on JAK 2/STAT 3 pathway was investigated in CB mice and NCI-H 282 cells treated with PMA using western blotting, ELISA,and immunohistochemical analysis. The JAK2 inhibitor AG490 was used in NCI-H292 cells to verify the effect of RGS on JAK2/STAT3 pathway. Results: A total of 286 compounds were identified in RGS, in which Liquiritin, Formononetin, Isoliquiritigenin, Salidroside, Ferulic and Morphine were reported to have significant anti-inflammatory activities. RGS treatment significantly improved the thickening of bronchial epithelium, decreased collagen deposition and secretion of mucus, and the levels of inflammatory factors in CB mice. Transcriptomics analysis showed that most of 402 differentially expressed genes in RGS-treated CB mice were related to inflammatory response. The results in CB mice and NCI-H292 cells showed that RGS reduced the phosphorylation level of JAK 2 and STAT 3 . In addition, the use of JAK2 inhibitor AG490 confirmed that JAK2/STAT3 pathway played a key role in the effects of RGS on CB. Conclusions: RGS suppresses inflammation and improves chronic bronchitis in NCI-H292 cells and CB mice, at least in part, via inhibiting the JAK2/STAT3 pathway. This study demonstrated that RGS could be a potential drug in treating CB disease.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3